Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc. (NasdaqCM:BIMI) on October 24, 2022. The closing of the Agreement is expected to take place late in the fourth quarter of 2022, subject to necessary regulatory approvals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | +5.77% | -10.57% | -49.77% |
Mar. 05 | Top Premarket Decliners | MT |
Jan. 05 | BIMI International Medical, Inc. Announces Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
-49.77% | 15.4M | |
+14.23% | 69.5B | |
+7.11% | 8.2B | |
-20.55% | 7.97B | |
-4.06% | 7.84B | |
+2.26% | 4.66B | |
+17.12% | 4.32B | |
+1.41% | 4.19B | |
-3.02% | 3.89B | |
+21.42% | 3.62B |
- Stock Market
- Equities
- BIMI Stock
- News BIMI Holdings Inc.
- Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc..